Debrief: release a bounded conclusion

High ferritin can represent storage elevation, inflammation, liver disease, metabolic disease, malignancy, cell injury, or overload. High saturation indicates increased circulating iron availability relative to TIBC, but timing and low transferrin can influence it. Together, the case supports a workup because the findings are compatible and collection context was documented.

C282Y homozygosity strengthens hereditary susceptibility evidence but does not establish tissue burden or injury. In patients with elevated indices who are not C282Y homozygotes, EASL requires hepatic iron overload by MRI or biopsy to establish hemochromatosis. MRI and biopsy are clinical-correlation tools outside the laboratory's interpretive scope.

The laboratory must use its own validated method, verified interval, QC process, and approved reporting workflow. CLIA and CAP requirements apply to method performance and interval appropriateness, while the cited Roche ferritin assay is only an exemplar, not this case method. Release the verified pattern and its limitations, then route the result through the local clinical and genetic policy pathway.